Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$138.42 - $180.31 $2,353 - $3,065
-17 Reduced 0.02%
92,744 $13.1 Million
Q4 2022

Feb 13, 2023

BUY
$162.42 - $220.56 $1.42 Million - $1.93 Million
8,761 Added 10.43%
92,761 $15.7 Million
Q2 2022

Aug 12, 2022

BUY
$140.68 - $188.02 $422,040 - $564,060
3,000 Added 3.7%
84,000 $13.6 Million
Q4 2021

Feb 11, 2022

SELL
$247.59 - $304.47 $594,216 - $730,728
-2,400 Reduced 2.88%
81,000 $21.5 Million
Q3 2021

Nov 12, 2021

BUY
$194.77 - $324.21 $272,678 - $453,894
1,400 Added 1.71%
83,400 $24.1 Million
Q1 2021

May 14, 2021

SELL
$180.37 - $226.26 $2.16 Million - $2.72 Million
-12,000 Reduced 12.77%
82,000 $15.9 Million
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $1.55 Million - $2.17 Million
10,500 Added 12.57%
94,000 $18 Million
Q3 2020

Nov 13, 2020

SELL
$122.51 - $158.27 $61,255 - $79,135
-500 Reduced 0.6%
83,500 $12.3 Million
Q2 2020

Aug 13, 2020

SELL
$94.33 - $140.48 $877,269 - $1.31 Million
-9,300 Reduced 9.97%
84,000 $10.4 Million
Q1 2020

May 14, 2020

BUY
$84.96 - $109.14 $705,168 - $905,862
8,300 Added 9.76%
93,300 $9.01 Million
Q4 2019

Feb 14, 2020

BUY
$73.84 - $93.08 $1.11 Million - $1.4 Million
15,000 Added 21.43%
85,000 $7.86 Million
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $5.37 Million - $6.69 Million
70,000 New
70,000 $5.37 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.59B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Atika Capital Management LLC Portfolio

Follow Atika Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.